Skip to main content

Algorithm Cuts Unnecessary Oophorectomy in Children, Teens

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

TUESDAY, Oct. 24, 2023 -- Adoption of a preoperative risk stratification algorithm might prevent unnecessary oophorectomy in pediatric and adolescent patients with benign ovarian disease, according to a study published in the Oct. 3 issue of the Journal of the American Medical Association.

Peter C. Minneci, M.D., from Nationwide Children’s Hospital in Columbus, Ohio, and colleagues assessed whether implementation of a consensus-based, preoperative risk stratification algorithm reduces unnecessary oophorectomies in 519 pediatric and adolescent patients with benign ovarian disease. The analysis included patients (aged 6 to 21 years) undergoing surgery for an ovarian mass in 11 U.S. children’s hospitals between August 2018 and January 2021.

The researchers found that benign disease was present in 96.9 percent in the preintervention cohort and 93.7 percent in the intervention cohort. There was an absolute reduction of 7.7 percent in the percentage of unnecessary oophorectomies (decreasing from 16.1 percent preintervention to 8.4 percent during the intervention). For identifying benign lesions, the algorithm test performance in the intervention cohort had a sensitivity of 91.6 percent, a specificity of 90.0 percent, a positive predictive value of 99.3 percent, and a negative predictive value of 41.9 percent. In the intervention phase, the proportion of misclassification (malignant disease treated with ovary-sparing surgery) was 0.7 percent.

“Unnecessary oophorectomies decreased with use of a preoperative risk stratification algorithm to identify lesions with a high likelihood of benign pathology that are appropriate for ovary-sparing surgery,” the authors write.

Several authors disclosed ties to industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2023

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.